Certuity’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $848K | Buy |
10,230
+1
| +0% | +$83 | 0.08% | 140 |
|
2025
Q1 | $830K | Sell |
10,229
-939
| -8% | -$76.2K | 0.09% | 134 |
|
2024
Q4 | $1.01M | Buy |
11,168
+2,494
| +29% | +$225K | 0.11% | 115 |
|
2024
Q3 | $857K | Sell |
8,674
-1,976
| -19% | -$195K | 0.09% | 139 |
|
2024
Q2 | $987K | Buy |
10,650
+540
| +5% | +$50.1K | 0.08% | 127 |
|
2024
Q1 | $959K | Sell |
10,110
-500
| -5% | -$47.4K | 0.08% | 115 |
|
2023
Q4 | $947K | Buy |
10,610
+501
| +5% | +$44.7K | 0.1% | 112 |
|
2023
Q3 | $738K | Sell |
10,109
-204
| -2% | -$14.9K | 0.09% | 100 |
|
2023
Q2 | $858K | Buy |
10,313
+1
| +0% | +$83 | 0.1% | 93 |
|
2023
Q1 | $786K | Hold |
10,312
| – | – | 0.12% | 81 |
|
2022
Q4 | $856K | Sell |
10,312
-9,100
| -47% | -$755K | 0.14% | 71 |
|
2022
Q3 | $1.54M | Buy |
19,412
+7,534
| +63% | +$598K | 0.36% | 39 |
|
2022
Q2 | $883K | Buy |
11,878
+470
| +4% | +$34.9K | 0.23% | 57 |
|
2022
Q1 | $1.03M | Sell |
11,408
-2,501
| -18% | -$225K | 0.22% | 75 |
|
2021
Q4 | $1.56M | Sell |
13,909
-2,801
| -17% | -$314K | 0.33% | 49 |
|
2021
Q3 | $2.1M | Hold |
16,710
| – | – | 0.42% | 45 |
|
2021
Q2 | $2.26M | Buy |
16,710
+166
| +1% | +$22.5K | 0.52% | 36 |
|
2021
Q1 | $2.24M | Buy |
16,544
+1,734
| +12% | +$235K | 0.6% | 31 |
|
2020
Q4 | $2.09M | Buy |
14,810
+3,405
| +30% | +$479K | 0.67% | 29 |
|
2020
Q3 | $1.27M | Buy |
11,405
+2,758
| +32% | +$307K | 0.5% | 33 |
|
2020
Q2 | $968K | Sell |
8,647
-446
| -5% | -$49.9K | 0.45% | 37 |
|
2020
Q1 | $704K | Buy |
9,093
+589
| +7% | +$45.6K | 0.39% | 46 |
|
2019
Q4 | $809K | Buy |
+8,504
| New | +$809K | 0.39% | 50 |
|